CLINICAL_TRIALS
trial_result
· 2020-06-02
Clinical Trial Update: CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM [Phase 4]
Summary
Phase 4 clinical trial evaluating a text messaging intervention to improve adherence to PrEP among high-risk men who have sex with men; completed with results p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, San Diego | Conditions: Patient Adherence, HIV Seronegativity | Phase 4 | Status: COMPLETED | Results posted: 2020-06-02